Osmitrol Injection, Solution
Product Images NDC 0338-0353

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Osmitrol (NDC 0338-0353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Osmitrol Injection Structural Formula (Image 01)

Chemical structure of Mannitol, the active ingredient in Osmitrol injection, solution. The diagram shows the molecular arrangement of Mannitol with hydroxyl groups attached to a carbon backbone.*

FDA Label Image

Osmitrol Injection Representative Container Label Ndc 0338-0351-04 (Image 02)

Label for Osmitrol 5% Injection (5% Mannitol Injection USP) in 1000 mL volume from Baxter Healthcare Company. The label indicates a 5 g Mannitol per 100 mL concentration, intravenuous sterile nonpyrogenic solution with adjusted pH and specified osmolarity. It includes handling instructions, container type (VIAFLEX PL 146 plastic), and Baxter Healthcare Corporation contact information.*

FDA Label Image

Image 03

A text panel for Osmitrol Injection showing 5% Mannitol Injection USP in a 14-1000 mL Viaflex container. The panel includes placeholders for expiration date and lot number, alongside labeled spaces for secondary and primary bar codes, with a sample barcode number shown.*

FDA Label Image

Image 04

Label for Osmitrol 10% Injection, containing 10% Mannitol Injection USP in 500 mL solution form. The label specifies sterile, nonpyrogenic, single-dose intravenous use with a pH of 5.0 adjusted with sodium hydroxide or hydrochloric acid. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA.*

FDA Label Image

Image 05

Label for Osmitrol Injection, 10% Mannitol Injection, USP, in a 24-500 mL Viaflex container. The label includes space for expiration date, lot number, and bar codes. Manufacturer is Baxter Healthcare Company.*

FDA Label Image

Image 06

Label for Osmitrol 15% Injection (15% Mannitol Injection USP), 500 mL solution for intravenous use. The label includes the Baxter Healthcare Company name and address, product NDC 0338-0355-03, and usage information including pH, osmolarity, and storage instructions. The container type is specified as VIAFLEX PL 146 plastic, manufactured by Baxter Healthcare in USA.*

FDA Label Image

Image 07

Label for Osmitrol Injection 15% (Mannitol Injection, USP) in a 24-500 mL Viaflex container. The label includes space for expiration date, lot number, and bar codes. The product is manufactured by Baxter Healthcare Company.*

FDA Label Image

Image 08

Label for Osmitrol 20% Injection (20% Mannitol Injection USP) solution, 250 mL vial. The label includes product strength, dosage form (injection), active ingredient (mannitol), volume, and manufacturer (Baxter Healthcare Company). Additional text provides pH, osmolarity, usage instructions, and storage details.*

FDA Label Image

Image 09

Label for Osmitrol 20% Injection (20% Mannitol Injection, USP) in a 250 mL Viaflex container. The label includes lot and expiration date placeholders and features primary and secondary bar codes. Manufacturer or labeler is not visible on this label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.